J&J’s Varipulse system achieves freedom for atrial arrhythmia recurrence

J&J’s Varipulse system achieves freedom for atrial arrhythmia recurrence

Submitted by admin on February 5, 2024 - 10:07am
Source: 
Clinical Trials Arena
News Tags: 
JNJ
Medtech
Varipulse
atrial arrhythmia
clinical trials
Headline: 
J&J’s Varipulse system achieves freedom for atrial arrhythmia recurrence
snippet: 

J&J MedTech’s Varipulse Platform demonstrated 12-month freedom from atrial arrhythmia recurrence in approximately 80% of the patients in inspIRE and admIRE trials.

Do Not Allow Advertisers to Use My Personal information